https://en.bioecon.ru/companies/sanofi/Recent content in Sanofi on BioeconHugoen-USWed, 29 Jul 2026 09:52:30 +0700https://en.bioecon.ru/technology/xenobiology-expanded-genetic-alphabet/Sun, 05 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/xenobiology-expanded-genetic-alphabet/Orthogonal biological systems built on xeno-nucleic acids, unnatural base pairs and genomically recoded organisms that incorporate noncanonical amino acids into proteins — enabling site-specific drug conjugation and a genetic firewall against horizontal gene transfer with wild species.https://en.bioecon.ru/technology/biopharmaceuticals-biomedicines/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biopharmaceuticals-biomedicines/Large-molecule therapeutics manufactured via living cells to treat complex diseases like cancer, diabetes, and autoimmune disorders.https://en.bioecon.ru/technology/biologics/Thu, 18 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biologics/Biologics — monoclonal antibodies, ADCs, CAR-T and gene therapy — are the largest and fastest-growing drug class, built on a reproducible cell-line platform at 2–10 g/L titers.